A Study to Investigate the Pharmacokinetics, Safety, Tolerability, and Efficacy of AZD0780 With Ezetimibe Combinations in Healthy Adults With Elevated LDL-C.

NCT06742853 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

81

Enrollment

INDUSTRY

Sponsor class

Conditions

Dyslipidemia

Interventions

DRUG: AZD0780
DRUG: Ezetimibe
DRUG: Rosuvastatin
DRUG: Bempedoic Acid
DRUG: Placebo

Sponsor

AstraZeneca